Most Read Articles
Fiel Soliven, 18 Mar 2015
The connection between prediabetes, diabetes, and risk of hepatocellular carcinoma (HCC) in HBsAg and anti-HCV seronegative patients, as well as the association between fasting glucose and HCC were examined in this study.
01 Feb 2016
Long-term ezetimibe improves lipid metabolism in dyslipidaemic patients with hepatobiliary disease, based on a study.
01 Feb 2016
Use of gadoxetate disodium for functional MRI can obtain useful data on hepatobiliary diseases, an article states.
Tristan Manalac, 14 Sep 2017
An 8-week regimen of sofosbuvir-velpatasvir-voxilaprevir combination is not noninferior to a 12-week regimen of sofosbuvir-velpatasvir for patients with chronic hepatitis C virus (HCV) infection, report two recent phase 3 open-label trials.

Highlights from APASL 2017

28 Jun 2017
In this edition of MIMS Hepatology Supplement, we bring you selected highlights from the 26th Conferences of the Asian Pacific Association for the Study of Liver held in Shanghai, China. 

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Fiel Soliven, 18 Mar 2015
The connection between prediabetes, diabetes, and risk of hepatocellular carcinoma (HCC) in HBsAg and anti-HCV seronegative patients, as well as the association between fasting glucose and HCC were examined in this study.
01 Feb 2016
Long-term ezetimibe improves lipid metabolism in dyslipidaemic patients with hepatobiliary disease, based on a study.
01 Feb 2016
Use of gadoxetate disodium for functional MRI can obtain useful data on hepatobiliary diseases, an article states.
Tristan Manalac, 14 Sep 2017
An 8-week regimen of sofosbuvir-velpatasvir-voxilaprevir combination is not noninferior to a 12-week regimen of sofosbuvir-velpatasvir for patients with chronic hepatitis C virus (HCV) infection, report two recent phase 3 open-label trials.